SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028164
Filing Date
2023-08-14
Accepted
2023-08-14 11:35:49
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 701910
2 ex31-1.htm EX-31.1 15023
3 ex31-2.htm EX-31.2 14945
4 ex32-1.htm EX-32.1 6300
5 ex32-2.htm EX-32.2 6271
  Complete submission text file 0001493152-23-028164.txt   3865973

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acut-20230630.xsd EX-101.SCH 23873
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acut-20230630_cal.xml EX-101.CAL 35508
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acut-20230630_def.xml EX-101.DEF 125568
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acut-20230630_lab.xml EX-101.LAB 252741
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acut-20230630_pre.xml EX-101.PRE 196879
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 596779
Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Filer) CIK: 0001850767 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56257 | Film No.: 231167560
SIC: 2834 Pharmaceutical Preparations